UBC, a biopharmaceutical company providing integrated clinical, safety and commercialization services, has announced that Bekki Brown, UBC’s chief operating officer, will be elevated to the role of president & chief executive officer, effective January 1, 2023.
 
Brown’s more than 20 years of senior management experience focused on strategic growth and operational excellence for industry-leading organizations such as Quintiles, INC Research and Syneos Health, will play an integral role in designing UBC’s long-term market position, expanding its service model and maintaining its financial strength.
 
“As we enter the post-COVID world of drug development, we embark on one of the most innovative markets in recent history,” said Patrick Lindsay, president & chief executive officer, UBC. “To best maximize our opportunities, we are now positioning UBC for significant growth, both organically and inorganically. I have the utmost confidence that Bekki will provide the vision, leadership, and management necessary to ensure UBC remains a standard bearer for innovation, quality, and safety in the life sciences industry as we continue to adapt, evolve and grow.”
 
In the new year, Lindsay will join the UBC Board of Directors serving as strategic advisor to the CEO and the organization.